Dear PDDI Task Force, I am please say that we have over 2 dozen responses to the short questionnaire on how to represent PDDI importance (https://pitt.co1.qualtrics.com/jfe/form/SV_e3rG1HYMzCDMLVX)! - If you have completed it - thank you! Please pass the link on to your colleagues. - If you have not completed - it will be open for 7 more days. thanks and kind regards. -Rich On 08/30/2018 09:44 AM, Richard Boyce wrote: > Dear Colleagues, > > The draft Community Group Note for the Minimum Information Model for > Potential Drug-drug Interaction (PDDI) Information currently > distinguishes the seriousness of a PDDI from its severity. However, > this might not be the best approach. > > We have created a short and simple survey is intended to elicit your > anonymous feedback on five potential alternatives to communicating the > importance of a PDDI to clinicians. Would you please consider > completing the survey by September 20th? > > *Link the survey:* > https://pitt.co1.qualtrics.com/jfe/form/SV_e3rG1HYMzCDMLVX > > > Please feel free to distribute to your colleagues and relevant listservs. > > We will compile all responses (anonymous) and use them to inform a > new proposal for this topic for inclusion in the final version of the > Note. > > > thank you and kind regards, > > -Rich > > > > -- > Richard D Boyce, PhD > Associate Professor of Biomedical Informatics and Clinical and > Translational Science in the Clinical and Translational > Science Institute > Director of the Informatics Core for the Center of Excellence for > Natural Product- Drug Interaction Research (NaPDI) > Faculty, Center for Pharmaceutical Policy and Prescribing > Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics > Research and Training Program > University of Pittsburgh > rdb20@pitt.edu > Office: 412-648-9219 > Twitter: @bhaapgh > -- Richard D Boyce, PhD Associate Professor of Biomedical Informatics and Clinical and Translational Science in the Clinical and Translational Science Institute Director of the Informatics Core for the Center of Excellence for Natural Product- Drug Interaction Research (NaPDI) Faculty, Center for Pharmaceutical Policy and Prescribing Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program University of Pittsburgh rdb20@pitt.edu Office: 412-648-9219 Twitter: @bhaapghReceived on Thursday, 13 September 2018 18:10:21 UTC
This archive was generated by hypermail 2.4.0 : Friday, 17 January 2020 19:52:59 UTC